These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9632004)

  • 1. Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons.
    Berman B; Flores F; Burke G
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):955-9. PubMed ID: 9632004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pruritic papular eruption in HIV.
    Eisman S
    Dermatol Clin; 2006 Oct; 24(4):449-57, vi. PubMed ID: 17010775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pruritic papular eruption associated with HIV-etiopathogenesis evaluated by clinical, immunohistochemical, and ultrastructural analysis.
    Ramos H; Pagliari C; Takakura CF; Sotto MN; Duarte MI
    J Dermatol; 2005 Jul; 32(7):549-56. PubMed ID: 16335870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the pruritic papular eruption of HIV.
    Aires JM; Rosatelli JB; de Castro Figueiredo JF; Roselino AM
    Int J Dermatol; 2000 Dec; 39(12):903-6. PubMed ID: 11168658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pruritic papular eruption in HIV seropositive patients: a cutaneous marker for immunosuppression.
    Boonchai W; Laohasrisakul R; Manonukul J; Kulthanan K
    Int J Dermatol; 1999 May; 38(5):348-50. PubMed ID: 10369543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pruritic papular eruption of HIV-disease.
    Bason MM; Berger TG; Nesbitt LT
    Int J Dermatol; 1993 Nov; 32(11):784-9. PubMed ID: 8270332
    [No Abstract]   [Full Text] [Related]  

  • 7. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
    Castelnuovo B; Byakwaga H; Menten J; Schaefer P; Kamya M; Colebunders R
    AIDS; 2008 Jan; 22(2):269-73. PubMed ID: 18097229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era.
    Chua SL; Amerson EH; Leslie KS; McCalmont TH; Leboit PE; Martin JN; Bangsberg D; Maurer TA
    Br J Dermatol; 2014 Apr; 170(4):832-9. PubMed ID: 24641299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pruritic papular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study.
    Afonso JP; Tomimori J; Michalany NS; Nonogaki S; Porro AM
    J Am Acad Dermatol; 2012 Aug; 67(2):269-75. PubMed ID: 22521200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology and risk factors associated with a pruritic papular eruption in people living with HIV in India.
    Farsani TT; Kore S; Nadol P; Ramam M; Thierman SJ; Leslie K; Chandrasekar C; Sikhamani R; Manoharan G; Kubba A; Maurer TA
    J Int AIDS Soc; 2013 Sep; 16(1):17325. PubMed ID: 24004854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline for the treatment of HIV infection and its complications.
    Dezube BJ; Lederman MM
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S139-42. PubMed ID: 8699854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
    Dezube BJ; Pardee AB; Chapman B; Beckett LA; Korvick JA; Novick WJ; Chiurco J; Kasdan P; Ahlers CM; Ecto LT
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):787-94. PubMed ID: 8099612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of AIDS manifesting pruritic papular eruptions and psoriasiform lesions: an immunohistochemical study of the lesional dermal infiltrates.
    Ichihashi N; Seishima M; Takahashi T; Muto Y; Kitajima Y
    J Dermatol; 1995 Jun; 22(6):428-33. PubMed ID: 7650242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.
    Smith KJ; Skelton HG; Yeager J; Lee RB; Wagner KF
    Dermatology; 1997; 195(4):353-8. PubMed ID: 9529556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and treatment of itching in HIV-infected patients.
    Gelfand JM; Rudikoff D
    Mt Sinai J Med; 2001; 68(4-5):298-308. PubMed ID: 11514917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intractable pruritus in HIV infection: immunologic characterization.
    Milazzo F; Piconi S; Trabattoni D; Magni C; Coen M; Capetti A; Fusi ML; Parravicini C; Clerici M
    Allergy; 1999 Mar; 54(3):266-72. PubMed ID: 10321563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pruritic papular eruptions and candidiasis due to HIV infection.
    Uchigasaki S; Baba S; Kakinuma H; Suzuki H; Sawada S; Kasori J; Okamoto T
    J Dermatol; 1996 Aug; 23(8):572-6. PubMed ID: 8854592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total IgE, mosquito saliva specific IgE and CD4+ count in HIV-infected patients with and without pruritic papular eruptions.
    Jiamton S; Kaewarpai T; Ekapo P; Kulthanan K; Hunnangkul S; Boitano JJ; Wongkamchai S
    Asian Pac J Allergy Immunol; 2014 Mar; 32(1):53-9. PubMed ID: 24641291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Features of Pruritic Papular Eruption of HIV Patients seen in Benin-City, Nigeria.
    Ekpe O; Onunu AN; Forae GD; Okwara B
    West Afr J Med; 2020; 37(1):53-57. PubMed ID: 32030712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of pruritic papular eruption with HIV infection in Uganda.
    Resneck JS; Van Beek M; Furmanski L; Oyugi J; LeBoit PE; Katabira E; Kambugu F; Maurer T; Berger T; Pletcher MJ; Machtinger EL
    JAMA; 2004 Dec; 292(21):2614-21. PubMed ID: 15572719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.